Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism (ZEST-PREP)
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism
Sponsor: Center of New Medical Technologies
A NA clinical study on Thyrotoxicosis, this trial is actively recruiting participants. The trial is conducted by Center of New Medical Technologies and has accumulated 6 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Not Yet Recruiting NA
-
Jul 2025 — Sep 2025 [monthly]
Not Yet Recruiting NA
-
Apr 2025 — Jul 2025 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Apr 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Center of New Medical Technologies
- S.LAB (SOLOWAYS)
For direct contact, visit the study record on ClinicalTrials.gov .